Skindex

Patient-Reported Outcomes in Vitiligo: DLQI, Vitiligo-Specific Scales, and What Counts as Clinically Meaningful

November 12, 2025 | vitiligo

Key Takeaways Why PROMs? Pigment changes affect visibility, stigma, and function. PROMs help prioritize sites (e.g., face/hands) and set goals […]

Psychosocial Impact of Vitiligo: Quality of Life, Stigma, and Support Strategies

September 10, 2025 | vitiligo

Key Takeaways Vitiligo imposes a clinically meaningful quality-of-life (QoL) burden; facial and visible-area involvement, rapid progression, and darker phototypes are

Vitiligo Epidemiology & Disease Burden: Global Prevalence, Children vs Adults, Quality of Life

August 26, 2025 | vitiligo

Key Takeaways Global point prevalence typically falls within ~0.5–2%, with heterogeneity by region and methodology. Childhood onset is common (≈30–50%